For nearly 25 years, the Sidney Kimmel Cancer Center – Jefferson Health has been a leader in oncology research, patient treatment, and cancer education.
Founded in 1991 as a stand-alone center with a staff of 30, we have grown into a clinical and research enterprise comprising 32 hospitals within our network and practices staffed by hundreds of oncology researchers and physicians from around the globe.
In 1996, with the generous support of Mr. Sidney Kimmel, the cancer center became known as the Kimmel Cancer Center and subsequently renamed the Sidney Kimmel Cancer Center in 2013.
Andrew Chapman, DO, FACP
Interim Enterprise Director, Sidney Kimmel Cancer Center and Executive Vice President of Oncology Services, Jefferson Health
Andrew Chapman, DO, FACP, is the Interim Executive Vice President of Oncology Services at Jefferson Health and Enterprise Director of the Sidney Kimmel Cancer Center, one of only 71 National Cancer Institute (NCI)-designated cancer centers nationwide. Dr. Chapman is currently overseeing cancer services and cancer research at all SKCC – Jefferson Health sites throughout the Greater Philadelphia region, reporting directly to Stephen K. Klasko, MD, MBA, President of Thomas Jefferson University and CEO of Jefferson Health. He is Chief of Cancer Services for SKCC; Co-director of the Jefferson Senior Adult Oncology Center; Professor and Vice Chair of Clinical Operations for the Department of Medical Oncology; and Clinical Professor in the Jefferson College of Nursing.
See Full BioNeal Flomenberg, MD
Enterprise Deputy Director for Clinical Integration, Sidney Kimmel Cancer Center
Professor & Chair, Department of Medical Oncology
Director, Blood and Marrow Transplant Program
Andrew Aplin, PhD
Enterprise Deputy Director for Scientific Strategy
Kalbach-Newton Professor in Cancer Research
Wm. Kevin Kelly, DO
Enterprise Associate Director for Clinical Research
Professor, Medical Oncology and Urology
Director, Division of Solid Tumor Oncology
Edith Peterson Mitchell, MD
Director, Center to Eliminate Cancer Disparities
Clinical Professor of Medicine and Medical Oncology
Associate Director, Diversity Affairs
Grace Lu-Yao, PhD, MPH
Enterprise Associate Director for Population Science
Vice Chair, Population Science, Department of Medical Oncology
Matthew Huesser, MBA
Enterprise Associate Director for Administration & Operations
Sidney Kimmel Cancer Center
Felix Kim, PhD
Enterprise Associate Director for Training and Education
Associate Professor, Department of Cancer Biology
Amy Leader, PhD, MPH
Enterprise Associate Director for for Community Integration
Director of Community Outreach & Engagement, Sidney Kimmel Cancer Center
Associate Professor, Division of Population Science, Department of Medical Oncology
Christopher McNair, PhD
Enterprise Associate Director for Data Science
Director of Cancer Informatics, Sidney Kimmel Cancer Center
Assistant Professor, Department of Cancer Biology
Matthias Schnell, PhD
Enterprise Associate Director for Shared Resources
Professor and Chair, Department of Immunology & Microbiology
Director, Jefferson Vaccine Center
Andrew Chapman, DO
Chief of Cancer Services, Sidney Kimmel Cancer Center
Vice Chair, Clinical Operations, Department of Medical Oncology
Co-director, Jefferson Senior Adult Oncology Center
Clinical Professor of Medical Oncology
Adam Dicker, MD, PhD
Enterprise SVP, Professor and Chair, Department of Radiation Oncology
Director, Jefferson Center for Digital Health
Alex Khariton, RTT, MBA
Vice President, Cancer Services
Senior Administrator, Sidney Kimmel Cancer Center
Leonard Gomella, MD
Senior Director Clinical Affairs, Sidney Kimmel Cancer Center
Bernard W. Godwin Professor of Prostate Cancer and Chair, Department of Urology
Clinical Director, Sidney Kimmel Cancer Network
Matthew Carabasi, MD
Senior Director, Strategic Oncology Partnerships
Professor and Vice Chair of Outreach
Director, Medical Oncology Specialty Network, Department of Medical Oncology
George C. Prendergast, PhD
President & CEO, Lankenau Institute for Medical Research
Professor, Lankenau Institute for Medical Research
Noreen M. Robertson, DMD
Consortium Liaison, Drexel University
Associate Vice Dean for Research, Drexel University College of Medicine
Mark Shahin, MD
Deputy Director, Asplundh Cancer Pavilion and Oncology Service Line Leader
Director, Hanjani Institute for Gynecologic Oncology
Asplundh Cancer Pavilion, Sidney Kimmel Cancer Center at Abington – Jefferson Health
Emma Laverty
Assistant Vice President of Development
Sidney Kimmel Cancer Center
Peter O'Connor
Administator
Sidney Kimmel Cancer Center
Lauren Riley
Manager, Cancer Marketing Service Line
Sidney Kimmel Cancer Center
Melissa Macarro
Director, Cancer Marketing Service Line - Jefferson Health
Sidney Kimmel Cancer Center
We're everywhere you live, work, and play.
Jefferson (Philadelphia University + Thomas Jefferson University) and Drexel University
Through this collaborative, multidisciplinary approach, researchers and clinicians from both institutions work together as they work to advance cancer research and treatment. Infrastructure is supported through integrated program meetings, symposia, participation in cancer center Grand Rounds, use of complementary shared resources, and teleconferencing for research activities among the institutions. Clinical research is guided by the cancer center’s Data Safety and Monitoring Board, formal Multi-Disciplinary Groups, a common Institutional Review Board (IRB) and Protocol Review Committee. The Sidney Kimmel Cancer Center Clinical Trials Office supports all cancer clinical trial activities, and provides public and professional access to the trials at Drexel University and SKCC.
Drexel University formally joined the consortium in 2013, strengthening a long-standing history of collaborative research, publications, and grants between investigators at the universities, most particularly as associated with cancer imaging, hormone-dependent cancers, clinical research, bioinformatics, and population-based studies assessing cancer risk and control. Drexel University also brings substantial strength in biomedical engineering, nanotechnology, and medicinal chemistry.
Members
Walter Curran, MD
J. Alan Diehl, PhD
Heide Ford, PhD
Felix Feng, MD
Geoffrey Greene, PhD
Maha Hussain, MD
Roy Jensen, MD
Lorelei Mucci, PhD
Members, cont.
Leon Platanias, MD, PhD
Timothy Rebbeck, PhD
Dana Rollison, PhD
Victoria Seewaldt, MD
Brian Springer, MHA
George Weiner, MD
Patricia Wiley
Ad Hoc Members
Edward Chu, MD
Jay Fox, PhD
R. Amanda C. LaRue, PhD
Electra Paskett, PhD
NCI–designated since 1996
Ranked among the best hospitals for cancer care by
U.S. News & World Report
Your Philadelphia Resource for Nationally Recognized Oncology Expertise
ONE of only 71 National Cancer Institute (NCI)-designated Cancer Centers in the U.S.
Delivering comprehensive care through 4 Advanced Care Hubs across the Delaware Valley
More than 8,900 patients seen annually
Ranked "Outstanding" by the National Cancer Institute (NCI)
First U.S. clinic to offer genetic testing and counseling for men with prostate cancer
Neu Center for Supportive Medicine and Survivorship One of the first centers to offers psychosocial support to cancer patients
Routinely ranked among the top cancer centers nationally by U.S. News & World Report
